SCHEMBL26074576

SCHEMBL26074576

CN(C)c1ccc(-c2ccc(-c3cc(C(=O)O)c4cc(I)ccc4n3)nc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF4A1 P60842 2/20 0.46
▸ DHODH Q02127 5/20 0.45
▸ HSD17B10 Q99714 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HIF1A Q16665 2/20 0.44
▸ PTGES O14684 1/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ CYP3A4 P08684 4/20 0.41
▸ EGFR P00533 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ EPRS1 P07814 1/20 0.41
▸ APP P05067 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075661 0.88 ALDH1A1 (0.56) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL23590114 0.88 DHODH (0.60) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074473 0.86 KDM4E (0.56) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074580 0.85 EIF4A1 (0.46) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL23590037 0.84 DHODH (0.45) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074463 0.83 KDM4E (0.58) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074524 0.82 DHODH (0.48) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074599 0.82 EIF4A1 (0.48) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074491 0.82 MCL1 (0.45) EIF4A1DHODHHSD17B10ALDH1A1HIF1A
SCHEMBL26074552 0.82 EIF4A1 (0.50) EIF4A1DHODHHSD17B10ALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD EIF4A1 4791/4885DHODH 1/4885HSD17B10 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback